On July 19, Becker Shareholder, Jie Chengying Xiu spoke as one of the panelists at the Asian Financial Society’s panel, “Can Chinese Companies Continue To Be Listed In the US.” The topics she discussed included the new SEC rules and regulations on China-related SPACs, the challenges and opportunities facing Chinese companies to be listed in the US, the controversies caused by the VIE structure, and the new PCAOB auditing related requirements.
Topics addressed included:
- What are the key issues preventing Chinese companies from listing in the US? Are there any long term or short term solutions for these challenges?
- Are there legitimate legal issues and concerns that created the controversy?
- What is the current development status of Chinese concept stocks and do they still have investment value?
- What are the regulation differences for stocks listed on the main board and OTC Market?
- What are the new SEC rules that allow it to delist Chinese stocks for failure to meet the new auditing requirements from PCAOB?
- What are the most current SEC requirements about SPAC disclosure on Chinese business target companies?
- Are VIE structures for Chinese companies still viable?
- What are the types of Chinese companies that are looking to list in the US exchanges?
- Companies from what other countries in Asia, besides China, are looking to list in the US?